{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:09:54Z","timestamp":1768568994668,"version":"3.49.0"},"posted":{"date-parts":[[2025,4,11]]},"group-title":"Genetic and Genomic Medicine","reference-count":30,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>\n                    The catechol-O-methyltransferase (\n                    <jats:italic>COMT<\/jats:italic>\n                    ) gene is involved in brain catecholamine metabolism, but its association with Parkinson\u2019s disease (PD) risk remains unclear.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>\n                    To investigate the relationship between\n                    <jats:italic>COMT<\/jats:italic>\n                    genetic variants and PD risk across diverse ancestries.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    We analyzed\n                    <jats:italic>COMT<\/jats:italic>\n                    variants in 2,251 PD patients and 2,835 controls of European descent using whole-genome sequencing from the Accelerating Medicines Partnership-Parkinson Disease (AMP-PD), along with 20,427 PD patients and 11,837 controls from 10 ancestries using genotyping data from the Global Parkinson\u2019s Genetics Program (GP2).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    Utilizing the largest case-control datasets to date, no significant enrichment of\n                    <jats:italic>COMT<\/jats:italic>\n                    risk alleles in PD patients was observed across any ancestry group after correcting for multiple testing. Among Europeans, no correlations with cognitive decline, motor function, motor complications, or time to LID onset were observed.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>\n                    These findings emphasize the need for larger, diverse cohorts to confirm the role of\n                    <jats:italic>COMT<\/jats:italic>\n                    in PD development and progression.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.04.11.25325572","type":"posted-content","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T20:00:31Z","timestamp":1744401631000},"source":"Crossref","is-referenced-by-count":0,"title":["Does\n                  <i>COMT<\/i>\n                  Play a Role in Parkinson\u2019s Disease Susceptibility Across Diverse Ancestral Populations?"],"prefix":"10.64898","author":[{"given":"Miguel","family":"Mart\u00edn-B\u00f3rnez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Shar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Ahmed","family":"Nour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shri N","family":"Megha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Nwaokorie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adedunni","family":"Olusanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Kuznetsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Bandres-Ciga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair J","family":"Noyce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lietsel","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"G\u00f3mez-Garre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1656-302X","authenticated-orcid":false,"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Peri\u00f1an","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025041423050701000_2025.04.11.25325572v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00218-x"},{"key":"2025041423050701000_2025.04.11.25325572v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104782"},{"key":"2025041423050701000_2025.04.11.25325572v1.3","doi-asserted-by":"publisher","DOI":"10.1086\/425589"},{"key":"2025041423050701000_2025.04.11.25325572v1.4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FPC.0000000000000056","article-title":"COMT gene and risk for Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"24","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"2025041423050701000_2025.04.11.25325572v1.5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/08919887221103580","article-title":"Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson\u2019s Disease: A Meta-Analysis and Systematic Review","volume":"36","year":"2023","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2025041423050701000_2025.04.11.25325572v1.6","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s10072-021-05509-3","article-title":"Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson\u2019s disease-a meta-analysis","volume":"42","year":"2021","journal-title":"Neurol Sci"},{"key":"2025041423050701000_2025.04.11.25325572v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.01.005"},{"key":"2025041423050701000_2025.04.11.25325572v1.8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.parkreldis.2018.02.015","article-title":"Catechol-O-methyltransferase (COMT) genetic variants are associated with cognitive decline in patients with Parkinson\u2019s disease","volume":"50","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"2025041423050701000_2025.04.11.25325572v1.9","first-page":"454351","article-title":"Meta-Analysis of the Effects of the Catechol-O-Methyltransferase Val158\/108Met Polymorphism on Parkinson\u2019s Disease Susceptibility and Cognitive Dysfunction","volume":"10","year":"2019","journal-title":"Front Genet"},{"key":"2025041423050701000_2025.04.11.25325572v1.10","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s10072-021-05829-4","article-title":"Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"43","year":"2022","journal-title":"Neurol Sci"},{"key":"2025041423050701000_2025.04.11.25325572v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00071-5"},{"key":"2025041423050701000_2025.04.11.25325572v1.12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28494"},{"key":"2025041423050701000_2025.04.11.25325572v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/g3journal\/jkae268"},{"key":"2025041423050701000_2025.04.11.25325572v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603"},{"key":"2025041423050701000_2025.04.11.25325572v1.15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw079"},{"key":"2025041423050701000_2025.04.11.25325572v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giw015"},{"key":"2025041423050701000_2025.04.11.25325572v1.17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26153"},{"key":"2025041423050701000_2025.04.11.25325572v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30320-5"},{"key":"2025041423050701000_2025.04.11.25325572v1.19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2020.0428","article-title":"Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study","volume":"77","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025041423050701000_2025.04.11.25325572v1.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01584-8"},{"key":"2025041423050701000_2025.04.11.25325572v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00283-1"},{"key":"2025041423050701000_2025.04.11.25325572v1.22","doi-asserted-by":"publisher","DOI":"10.1126\/science.1131262"},{"key":"2025041423050701000_2025.04.11.25325572v1.23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.29126","article-title":"Underrepresented populations in Parkinson\u2019s genetics research: Current landscape and future directions","volume":"37","year":"2022","journal-title":"Mov Disord"},{"key":"2025041423050701000_2025.04.11.25325572v1.24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0028-3886.108121","article-title":"The COMT Val158Met polymorphism as an associated risk factor for Parkinson\u2019s disease in Asian rather than Caucasian populations","volume":"61","year":"2013","journal-title":"Neurol India"},{"key":"2025041423050701000_2025.04.11.25325572v1.25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/01616412.2018.1564183","article-title":"COMT Val158Met polymorphism and Parkinson\u2019s disease risk: a pooled analysis in different populations","volume":"41","year":"2019","journal-title":"Neurol Res"},{"key":"2025041423050701000_2025.04.11.25325572v1.26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10072-014-1896-0","article-title":"Val158Met polymorphism of COMT gene and Parkinson\u2019s disease risk in Asians","volume":"36","year":"2015","journal-title":"Neurol Sci"},{"key":"2025041423050701000_2025.04.11.25325572v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(96)13289-4"},{"key":"2025041423050701000_2025.04.11.25325572v1.28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41531-023-00573-2","article-title":"Geneticmeta-analysis of levodopa induced dyskinesia in Parkinson\u2019s disease","volume":"9","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"2025041423050701000_2025.04.11.25325572v1.29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/mds.23805","article-title":"Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson\u2019s disease","volume":"27","year":"2012","journal-title":"Mov Disord"},{"key":"2025041423050701000_2025.04.11.25325572v1.30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson\u2019s disease susceptibility and cognitive symptom progression","volume":"6","year":"2016","journal-title":"J Parkinsons Dis"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.04.11.25325572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:33:46Z","timestamp":1768509226000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.04.11.25325572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1101\/2025.04.11.25325572","relation":{},"subject":[],"published":{"date-parts":[[2025,4,11]]},"subtype":"preprint"}}